Monday, December 21, 2009
FIRMAGON® has a significantly greater probability of PSA recurrence-free survival than leuprolide in prostate cancer patients
-----------------------------------------------------------------------------------------------
Monday, December 21, 2009
-----------------------------------------------------------------------------------------------